I agree with much of your analysis whytee. As share holders we are stuck between a rock and a hard place. The current BoD have overseen a flawed trial design, they have failed to communicate with shareholders, and have been lacking in a definitive way forward (plan). But...conversly, the suggested replacements on the BoD could lack street cred in overseeing therapeutic trials, affording limited reputational confidence in the marketplace and creating yet another problem for shareholders and the company.
So, I too hold reservations on whether the proposed changes can in fact lead to any tangible benefits. However, based on past behaviour, the current BoD shows little strategic ability to move us out of the quagmire that we are now in. As always - great analysis whytee.
- Forums
- ASX - By Stock
- 1AI
- Pacific Channel releases updated internal analysis of LCT 10/09/2019
Pacific Channel releases updated internal analysis of LCT 10/09/2019, page-6
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $1.4K | 199.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 6404404 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1428102 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 6404404 | 0.006 |
11 | 4577719 | 0.005 |
6 | 3695009 | 0.004 |
2 | 3100000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1428102 | 2 |
0.008 | 2252112 | 10 |
0.009 | 2028673 | 10 |
0.010 | 2788587 | 5 |
0.011 | 208125 | 2 |
Last trade - 11.17am 11/10/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |